ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

Mirae Asset Healthcare Fund

MIRAE Mirae Asset Mutual Fund Mar 2026 — Sep 2026 7 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹3,493 CrAt NSE closes, Sep 2026
Companies held2929 with an NSE price
Top 10 holdings58.4%Of the equity shown here
Largest holding10.2%Sun Pharmaceutical Industries Limited
12-month turnover9.8%Estimated from 6 monthly disclosures · compare

Days to sell half: 4.2 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

7 priced months, Mar 2026 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

58.4% now · highest 61.1%, lowest 58.4%

Companies held

29 now · largest single holding 10.2% of equity

How it trades: no clear lean toward recent winners or losers (score -0.13 over 6 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 24 shared73.5%
  2. ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 18 shared72.4%
  3. EODWHFEdelweiss · 20 shared72.4%
  4. DSP Nifty Healthcare Index FundDSP · 18 shared72.4%
  5. ICICI Prudential Nifty Healthcare ETFICICI Prudential · 18 shared72.4%
  6. Axis NIFTY Healthcare ETFAxis · 18 shared72.4%
  7. DSP Nifty Healthcare ETFDSP · 18 shared72.4%
  8. Bandhan BSE Healthcare Index FundBandhan · 25 shared65.6%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 0 Companies added
Complete exits 0 Companies sold out
Increases 10 More shares than last month
Reductions 5 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 10.15% 355 Cr 0.20 Cr by Mar 2026 (7 mo+)
Divi's Laboratories Limited Healthcare Large Cap 9.79% 342 Cr 0.04 Cr by Mar 2026 (7 mo+)
Torrent Pharmaceuticals Limited Healthcare Large Cap 6.80% 238 Cr 0.05 Cr by Mar 2026 (7 mo+)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 5.62% 196 Cr 0.02 Cr by Mar 2026 (7 mo+)
Laurus Labs Limited Healthcare Mid Cap 5.51% 193 Cr 0.10 Cr by Mar 2026 (7 mo+)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 4.84% 169 Cr 0.14 Cr by Mar 2026 (7 mo+)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 4.78% 167 Cr 0.07 Cr by Mar 2026 (7 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 3.78% 132 Cr 0.08 Cr by Mar 2026 (7 mo+)
Alkem Laboratories Limited Healthcare Mid Cap 3.76% 131 Cr 0.03 Cr by Mar 2026 (7 mo+)
IPCA Laboratories Limited Healthcare Mid Cap 3.39% 118 Cr 0.06 Cr by Mar 2026 (7 mo+)
Krishna Institute of Medical Sciences Limited Healthcare Small Cap 3.39% 118 Cr 0.16 Cr by Mar 2026 (7 mo+)
Aster DM Quality Care Limited Healthcare Small Cap 3.33% 116 Cr 0.17 Cr by Mar 2026 (7 mo+)
Sai Life Sciences Limited Healthcare Small Cap 3.23% 113 Cr 0.07 Cr by Mar 2026 (7 mo+)
Onesource Specialty Pharma Limited Healthcare Small Cap 3.01% 105 Cr 0.07 Cr by Mar 2026 (7 mo+)
Fortis Healthcare Limited Healthcare Mid Cap 2.94% 103 Cr 0.13 Cr by Mar 2026 (7 mo+)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 2.90% 101 Cr 0.05 Cr by Mar 2026 (7 mo+)
Gland Pharma Limited Healthcare Small Cap 2.69% 93.92 Cr 0.03 Cr by Mar 2026 (7 mo+)
Cipla Limited Healthcare Large Cap 2.63% 92.01 Cr 0.07 Cr by Mar 2026 (7 mo+)
Eris Lifesciences Limited Healthcare Small Cap 2.39% 83.38 Cr 0.07 Cr by Mar 2026 (7 mo+)
Max Healthcare Institute Limited Healthcare Large Cap 2.35% 81.96 Cr 0.09 Cr by Mar 2026 (7 mo+)
Lupin Limited Healthcare Mid Cap 2.27% 79.21 Cr 0.04 Cr by Mar 2026 (7 mo+)
Mankind Pharma Limited Healthcare Mid Cap 2.24% 78.35 Cr 0.03 Cr by Mar 2026 (7 mo+)
Biocon Limited Healthcare Mid Cap 2.01% 70.05 Cr 0.19 Cr by Mar 2026 (7 mo+)
Molbio Diagnostics Limited Not classified — 1.77% 61.89 Cr 0.05 Cr Aug 2026 (2 mo)
Symbiotec Pharmalab Limited Not classified — 1.60% 55.81 Cr 0.05 Cr Aug 2026 (2 mo)
Neogen Chemicals Limited Chemicals Small Cap 1.50% 52.53 Cr 0.02 Cr by Mar 2026 (7 mo+)
Anthem Biosciences Limited Healthcare Mid Cap 0.93% 32.45 Cr 0.04 Cr by Mar 2026 (7 mo+)
Deepak Nitrite Limited Chemicals Small Cap 0.40% 14.00 Cr 91,539 by Mar 2026 (7 mo+)
Narayana Hrudayalaya Ltd. Healthcare Mid Cap 0.00% 0.04 Cr 199 by Mar 2026 (7 mo+)

Half of its current holdings have been held for 7 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Aster DM Quality Care Limited Sep 2026 ▲ Increasing +0.03 Cr
Narayana Hrudayalaya Ltd. Sep 2026 ▼ Reducing -0.02 Cr
Dr. Reddy's Laboratories Limited Sep 2026 ▲ Increasing +0.02 Cr
Symbiotec Pharmalab Limited Sep 2026 ▲ Increasing +0.01 Cr
Neogen Chemicals Limited Sep 2026 ▲ Increasing +0.01 Cr
Krishna Institute of Medical Sciences Limited Sep 2026 ▲ Increasing +0.01 Cr
Anthem Biosciences Limited Sep 2026 ▼ Reducing -70,000
Sai Life Sciences Limited Sep 2026 ▼ Reducing -64,500
Biocon Limited Sep 2026 ▲ Increasing +50,000
Alkem Laboratories Limited Sep 2026 ▲ Increasing +28,500
Gland Pharma Limited Sep 2026 ▲ Increasing +23,750
Apollo Hospitals Enterprise Limited Sep 2026 ▲ Increasing +4,200
Divi's Laboratories Limited Sep 2026 ▼ Reducing -4,000
IPCA Laboratories Limited Sep 2026 ▼ Reducing -2,662
Dr. Lal Path Labs Ltd. Sep 2026 ▲ Increasing +1,483
Molbio Diagnostics Limited Aug 2026 ▲ New position +0.05 Cr
Symbiotec Pharmalab Limited Aug 2026 ▲ New position +0.04 Cr
Dr. Reddy's Laboratories Limited Aug 2026 ▲ Increasing +0.02 Cr
Biocon Limited Aug 2026 ▲ Increasing +0.02 Cr
Glenmark Pharmaceuticals Limited Aug 2026 ▼ Reducing -0.01 Cr
Aster DM Quality Care Limited Aug 2026 ▲ Increasing +0.01 Cr
Lupin Limited Aug 2026 ▼ Reducing -76,000
Aurobindo Pharma Limited Aug 2026 ▼ Reducing -43,853
Sun Pharmaceutical Industries Limited Aug 2026 ▲ Increasing +40,000
Anthem Biosciences Limited Aug 2026 ▼ Reducing -40,000
Fortis Healthcare Limited Aug 2026 ▲ Increasing +40,000
Narayana Hrudayalaya Ltd. Aug 2026 ▼ Reducing -31,662
Mankind Pharma Limited Aug 2026 ▲ Increasing +28,500
Sai Life Sciences Limited Aug 2026 ▼ Reducing -25,000
Cipla Limited Aug 2026 ▼ Reducing -25,000
Eris Lifesciences Limited Aug 2026 ▼ Reducing -17,672
Alkem Laboratories Limited Aug 2026 ▲ Increasing +13,000
Gland Pharma Limited Aug 2026 ▲ Increasing +10,000
Apollo Hospitals Enterprise Limited Aug 2026 ▲ Increasing +7,950
Torrent Pharmaceuticals Limited Aug 2026 ▼ Reducing -7,000
Onesource Specialty Pharma Limited Aug 2026 ▲ Increasing +6,083
Biocon Limited Jul 2026 ▲ Increasing +0.13 Cr
J.B. Chemicals & Pharmaceuticals Lt Jul 2026 ▼ Complete exit -0.09 Cr
Torrent Pharmaceuticals Limited Jul 2026 ▲ Increasing +0.05 Cr
Lupin Limited Jul 2026 ▼ Reducing -89,000
Aurobindo Pharma Limited Jul 2026 ▼ Reducing -59,122
Krishna Institute of Medical Sciences Limited Jul 2026 ▼ Reducing -50,000
Glenmark Pharmaceuticals Limited Jul 2026 ▼ Reducing -46,692
Gland Pharma Limited Jul 2026 ▼ Reducing -35,000
Sai Life Sciences Limited Jul 2026 ▼ Reducing -30,000
Onesource Specialty Pharma Limited Jul 2026 ▲ Increasing +25,000
Laurus Labs Limited Jul 2026 ▼ Reducing -15,000
Mankind Pharma Limited Jul 2026 ▲ Increasing +15,000
Alkem Laboratories Limited Jul 2026 ▲ Increasing +6,000
Sudeep Pharma Limited Jun 2026 ▼ Complete exit -0.02 Cr
Max Healthcare Institute Limited Jun 2026 ▲ Increasing +0.01 Cr
Onesource Specialty Pharma Limited Jun 2026 ▲ Increasing +0.01 Cr
Krishna Institute of Medical Sciences Limited Jun 2026 ▲ Increasing +91,467
Glenmark Pharmaceuticals Limited Jun 2026 ▲ Increasing +29,000
Lupin Limited Jun 2026 ▼ Reducing -27,500
Dr. Reddy's Laboratories Limited Jun 2026 ▲ Increasing +25,922
Dr. Lal Path Labs Ltd. Jun 2026 ▲ Increasing +20,000
Gland Pharma Limited Jun 2026 ▲ Increasing +19,438
Narayana Hrudayalaya Ltd. Jun 2026 ▼ Reducing -16,000
Alkem Laboratories Limited Jun 2026 ▲ Increasing +6,000
IPCA Laboratories Limited Jun 2026 ▲ Increasing +5,000
Biocon Limited May 2026 ▼ Reducing -0.06 Cr
Dr. Lal Path Labs Ltd. May 2026 ▲ Increasing +60,000
Eris Lifesciences Limited May 2026 ▲ Increasing +59,782
Sudeep Pharma Limited May 2026 ▼ Reducing -46,243
Aster DM Quality Care Limited May 2026 ▼ Reducing -40,000
Mankind Pharma Limited May 2026 ▲ Increasing +40,000
Max Healthcare Institute Limited May 2026 ▲ Increasing +32,500
IPCA Laboratories Limited May 2026 ▲ Increasing +30,927
Rubicon Research Limited May 2026 ▼ Complete exit -30,747
Dr. Reddy's Laboratories Limited May 2026 ▲ Increasing +25,000
Wockhardt Limited May 2026 ▼ Complete exit -21,796
Alkem Laboratories Limited May 2026 ▲ Increasing +10,000
Onesource Specialty Pharma Limited May 2026 ▲ Increasing +6,836
Syngene International Limited May 2026 ▼ Complete exit -2,181
SAGILITY LIMITED Apr 2026 ▼ Complete exit -0.37 Cr
Max Healthcare Institute Limited Apr 2026 ▲ Increasing +0.04 Cr
Rubicon Research Limited Apr 2026 ▼ Reducing -0.03 Cr
Eris Lifesciences Limited Apr 2026 ▲ Increasing +90,456
Aster DM Quality Care Limited Apr 2026 ▼ Reducing -59,200
Cipla Limited Apr 2026 ▼ Reducing -50,000
Dr. Reddy's Laboratories Limited Apr 2026 ▲ Increasing +40,700
Anthem Biosciences Limited Apr 2026 ▼ Reducing -38,309
Glenmark Pharmaceuticals Limited Apr 2026 ▼ Reducing -27,500
Alkem Laboratories Limited Apr 2026 ▲ Increasing +21,999
Dr. Lal Path Labs Ltd. Apr 2026 ▲ Increasing +20,000
Aurobindo Pharma Limited Apr 2026 ▼ Reducing -20,000
Lupin Limited Apr 2026 ▼ Reducing -20,000
Narayana Hrudayalaya Ltd. Apr 2026 ▲ Increasing +16,500
IPCA Laboratories Limited Apr 2026 ▲ Increasing +11,000
Divi's Laboratories Limited Apr 2026 ▲ Increasing +5,000
Sudeep Pharma Limited Apr 2026 ▼ Reducing -1,832
J.B. Chemicals & Pharmaceuticals Lt Apr 2026 ▲ Increasing +1,080
Sun Pharmaceutical Industries Limited Apr 2026 ▲ Increasing +828

Changes compare consecutive month-end disclosures for this portfolio only.